-
Loading metrics
Structure-based drug repositioning explains ibrutinib as VEGFR2 inhibitor
- Melissa F. Adasme,
- Daniele Parisi,
- Kristien Van Belle,
- Sebastian Salentin,
- V. Joachim Haupt,
- Gary S. Jennings,
- Jörg-Christian Heinrich,
- Jean Herman,
- Ben Sprangers,
- Thierry Louat
x
- Published: May 27, 2020
- https://doi.org/10.1371/journal.pone.0233089
- See the preprint